BreatheAmerica

BreatheAmerica

The BreatheAmerica Difference | BreatheAmerica. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€18—27m (Dealroom.co estimates Nov 2012.)
Albuquerque New Mexico (HQ)
  • Edit
DateInvestorsAmountRound

N/A

Series A

$22.0m

Series B

$5.0m

Early VC
N/A

$2.8m

Debt
Total Funding€24.5m

Recent News about BreatheAmerica

Edit
More about BreatheAmericainfo icon
Edit

Breathe America is a specialized healthcare provider focused on treating respiratory and airway conditions such as asthma, allergies, and sinus infections. The company operates treatment centers in Louisiana and New Mexico but accepts patients from across the United States. Breathe America assembles a team of allergists, immunologists, ENT specialists, and respiratory experts to deliver comprehensive care. The business primarily serves individuals suffering from respiratory issues, offering personalized treatment plans after an initial visit. The market it operates in includes healthcare services, specifically targeting respiratory and allergy care. Breathe America generates revenue through patient consultations, treatments, and follow-up care. The company emphasizes the interconnectedness of the upper and lower airways, ensuring a holistic approach to treatment. Due to COVID-19, some services like Pulmonary Function Tests (PFTs) are temporarily unavailable.

Keywords: asthma, allergies, respiratory care, immunologists, ENT specialists, sinus infections, personalized treatment, healthcare services, Louisiana, New Mexico.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.